Risk of atypical femur fracture versus fragility fracture prevention with bisphosphonates.

Forty-four cases in the UK within the last five years.

Which compound should you recommend for supplementation?

New evidence that romosozumab may lead to excess cardiovascular complications.

Research presented at the virtual European Society of Human Genetics 2020 conference.

The definition used in current guidelines no longer relates to the population for whom osteoporosis drugs are recommended, experts say.

12 cohort studies involving more than 275,000 participants were evaluated.

Denosumab significantly decreased vertebral fracture risk, but nonvertebral fractures rose short-term.

Serum vitamin D concentration <10 ng/mL is a marker of severe LDD and LBP.

The study from Sweden finds a lower risk the year before TKR, increased risk the year after.

A cross-sectional cohort of >6,000 middle-aged and older Chinese participants.

Findings from a new randomised controlled trial of 160 obese older adults.

Patient-level pooled analysis of nearly 3000 randomized women with osteoporosis.

Results suggest it does, but results vary somewhat by site and by menopausal status.